The programme
The rise of AI has created an unprecedented technological boom, leading to the rapid transformation of many sectors, including Life Sciences, simultaneously raising significant ethical and regulatory questions.
Join EPLA for a focused online workshop exploring the evolving landscape of artificial intelligence in Pharma and MedTech law, with a particular emphasis on real-world regulatory and compliance challenges. The session will provide an in-house perspective on the operational impact of AI, covering key areas such as data privacy, governance, cybersecurity, HR, and employment law considerations in the deployment of AI systems within life sciences organisations. This will be followed by a deep dive into liability in the context of AI, addressing emerging legal risks and responsibilities for companies operating in highly regulated environments. The workshop will also include a presentation on the patentability of AI-based inventions in the pharmaceutical field.
With contributions from leading legal and industry specialists, this session will offer practical insights, real-world perspectives, and an interactive Q&A designed to support professionals navigating the complex regulatory ecosystem surrounding AI in life sciences.
| Overview from an in-house perspective Janice Carling – Teva Pharmaceuticals |
| The impact of the new Product Liability Directive Olivier Mignolet – Simmons & Simmons |
| AI & IP: patentability of AI-based inventions in the pharmaceutical field Caroline Pallard – IPSILON |
| Discussion & Q&A |
